Skip to main content

Table 2 Baseline Vaccine-Eligibility, Initiation, and Completion of Recommended Vaccinations Among Adult Refugees in a Connecticut district, 2013–2015

From: Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013–2015

 

Baseline Immunity Among All 111 Subjects at the Time of Resettlement

n (%)

Vaccinations One Year after Resettlement Among Vaccine-Eligible Subjects

n (%)

Vaccine

Immune

Non-immune (Vaccine-Eligible)

Initiated

Completed

Aggregatea

27 (24%)

84 (76%)

78 (93%)

42 (50%)

MMR (2 doses)

83 (75%)

28 (25%)

26 (93%)

20 (71%)

Hep A (2 doses)

93 (84%)

18 (16%)

16 (89%)

15 (83%)

Hep B (3 doses)

33 (30%)

78 (70%)

72 (92%)

46 (59%)

Tdap (1 dose)

N/A

111 (100%)

106 (96%)

106 (96%)

HPV (3 doses)b

N/A

34 (31%)

5 (15%)

1 (20%)

Varicella

100 (90%)

11 (10%)

N/A

N/A

  1. Note: MMR Measles, mumps, rubella, Hep A Hepatitis A, Hep B Hepatitis B, Tdap Tentanus, diphtheria, acellular pertussis, HPV Human papillomavirus. Baseline immunity determined by laboratory testing for immunoglobulin G or documentation of completed overseas vaccination
  2. a Aggregate of measles, mumps, rubella, hepatitis A/B; we considered subjects to be vaccine-eligible if they required any of these vaccines
  3. b HPV vaccine eligibility was assumed for all subjects < 26 years-old. No subject had documentation of prior HPV vaccination
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us